IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM

被引：0
|
作者：
Nahid, N. [1 ]
Kanumuri, S. [1 ]
Sharma, A. [1 ]
Wang, D. [1 ]
Johnson, J. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-080
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [41] Metabolism of antipsychotics and CYP2D6 genotype
    Schmider, J
    Walter, S
    Sachse, C
    Bauer, S
    Müller-Oerlinghausen, B
    Roots, I
    Brockmöller, J
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R459 - R459
  • [42] Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia
    Iwahashi, K
    [J]. ACTA NEUROPSYCHIATRICA, 2004, 16 (04) : 229 - 230
  • [43] Purification, biochemical characterization and comparative enzyme kinetics of recombinant human CYP2D6 1 and CYP2D6 2 variants
    Yu, AM
    Haining, RL
    [J]. BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES, 2001, 500 : 327 - 330
  • [44] The hypoalgesic effect of tramadol in relation to CYP2D6
    Poulsen, L
    ArendtNielsen, L
    Brosen, K
    Sindrup, SH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) : 636 - 644
  • [45] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [46] Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
    Doki, Kosuke
    Sekiguchi, Yukio
    Kuga, Keisuke
    Aonuma, Kazutaka
    Homma, Masato
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 257 - 262
  • [47] Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice
    Tolledo, Cole
    Stocco, Marlaina R.
    Miksys, Sharon
    Gonzalez, Frank J.
    Tyndale, Rachel F.
    [J]. MOLECULAR NEUROBIOLOGY, 2020, 57 (06) : 2509 - 2520
  • [48] Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients:: therapeutic consequences?
    Haffen, E
    Vandel, P
    Paintaud, G
    Broly, F
    Vandel, S
    Bonin, B
    Bizouard, P
    Sechter, D
    Bechtel, PR
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (11-12) : 877 - 879
  • [49] Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity Role of CYP2D6 and CYP2C19 in longevityRole of CYP2D6 and CYP2C19 in longevity
    L. Bathum
    K. Andersen-Ranberg
    J. Boldsen
    K. Brøsen
    B. Jeune
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 427 - 430
  • [50] CYP2D6 genotyping in Asians: An algorithm based upon determination of CYP2D6*4,*5, and*10 alleles
    Kwong, EH
    Levine, M
    Montgomery, CJ
    Chang, TKH
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 : 116 - 116
12345